Physician
Endocrinology
Dr. Michael L. Hancock, MD
|
|
Give Review
Michael Hancock is an expert in the field of Endocrinology. He graduated from Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He received 2 awards: "Diabetes Recognition Program" and "CMS Meaningful Use Stage 1 Certification". Doctor Michael L. Hancock, MD is a published doctor and has 27 publications published. The lastest was: 'Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer.' He is registered with Medicare and accepts Medicare payments.
Publications
- Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone With Reduced Side Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer.
- TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia.
- Effects of enobosarm on muscle wasting and physical function in patients With cancer: a double-blind, randomised controlled phase 2 trial.
- Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene.
- Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
- Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
- Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer.
- The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of...
- Factors associated With vertebral fractures in men treated With androgen deprivation therapy for prostate cancer.
- Race, sex, and the regulation of urine osmolality: observations made during water deprivation.
- Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults With acute lymphoblastic leuke...
- Phase I trial of imatinib in children With newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
- Establishing the use of body mass index as an indicator of nutrition risk in children With cancer.
- Phase II study of oxaliplatin in children With recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid...
- Phase I trial of intrathecal spartaject busulfan in children With neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
- Early complications in children With acute lymphoblastic leukemia presenting With hyperleukocytosis.
- Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
- Clinical presentation and treatment outcome of children With Burkitt lymphoma in Lebanon: a single institution's experience.
- Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genoType and CAR (constitutive androstane receptor) expression.
- Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
- Use of peripheral blood instead of bone marrow to monitor residual disease in children With acute lymphoblastic leukemia.
- De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination With methotrexate in vivo.
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.
- Outcomes of Growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.
- Selective androgen receptor modulators for the treatment of late onset male hypogonadism.
- Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
Schools
Indiana University School of Medicine
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Emblem Health
- Golden Rule
- GEHA
- Medicare Advantage PFFS
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Planned Administration Inc
- Pyramid Life
- Sagamore Plus
- Saint Francis Health Network
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Diabetes Recognition Program
- CMS Meaningful Use Stage 1 Certification
Education
-
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1588745343 | |
| NPPES Provider LastName | HANCOCK | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 462376398 | |
| NPPES Provider State | IN | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 3615.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588745343 |
| Last Name Of The Provider | HANCOCK |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. James A. Scheidler, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ana Priscu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmed F. Aljebawi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik A. Imel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa K. Cavaghan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paris Roach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine L. Bain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raghavendra G. Mirmira, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Myron H. Weinberger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|